Teva’s generic EpiPen approved in the U.S., with perfect timing
August 16, 2018 at 14:25 PM EDT
The U.S. has had monthslong shortages of Mylan’s EpiPen and other products, causing parents to worry as back-to-school season approaches.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|